You are here: All Products  > Chi-Med Completes Enrollment of Fruquintinib Phase III Trial in CRC

Chi-Med Completes Enrollment of Fruquintinib Phase III Trial in CRC

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products